Apr 9, 2021 in News
For Immediate Release April 8th, 2021 Re: Announcement that TEC Edmonton will cease operations effective June 30th, 2021 Applied Pharmaceutical Innovation (API) wishes to acknowledge......
We focus on business, regulatory & patent strategy, regulatory compliant toxicology, synthesis, formulation, PK/PD, clinical trial design, and the ability to take a compound all the way from the research bench to the patient’s bedside.
We are a not-for-profit that partners with Industry, supports researchers and startups, and leverages post-doctoral, graduate, and undergraduate students to bring life-saving research to the real world.
We have created a framework that bridges the gap in drug development. It is timely, ensures intellectual property stays with the funder, and is guided by experts in commercial drug development.
We provide the support of a full pharmaceutical company to academic researchers who have an idea. We help Industry access research innovation in a framework that supports commercial success.
Sign up to receive industry updates and news from API.